iRhythm and Lucem Health Partner to Introduce Predictive AI Solution for Early Detection of Arrhythmias in Patient Populations with Comorbid Conditions

iRhythm and Lucem Health Partner to Introduce Predictive AI Solution for Early Detection of Arrhythmias in Patient Populations with Comorbid Conditions

Clearwater Launches New Enterprise Cyber Risk Management Solution to Help Healthcare Organizations Reduce Cyber Risk, Strengthen Compliance, and Drive Boardroom Confidence

Clinisys Acquires Orchard Software

Clinisys announces the acquisition of Orchard Software from Francisco Partners, a leading global investment firm that specializes in partnering with technology businesses. The acquisition brings together two leaders in the LIS market and reaffirms Clinisys’s continued commitment to provide the laboratory informatics marketplace with cutting edge software advancements.

Symbiosis Reaches Major Milestone with 1,000th Batch of Injectable Drug Product

MAGENTIQ EYE Secures Series A Investment Led by aMoon to Drive the Future of AI-Powered Gastroenterology

MAGENTIQ EYE Secures Series A Investment Led by aMoon to Drive the Future of AI-Powered Gastroenterology

Camgenium Develops App to Improve Outcomes for Prostate Cancer Patients Before and After Surgery

Camgenium today announced its partnership with Professor Petre Cristian Ilie, Consultant Urological and Robotic Surgeon at NNUH NHS Foundation Trust, to develop HealthiumPro, a cloud-based innovative software solution. The system has the potential to improve the outcomes of prostate cancer patients by enhancing safety before and after surgery.

Vidir Solutions Introduces VLM Mini for Healthcare, Pharmaceutical, and Laboratory Storage

Compact Vertical Lift Module Engineered for Low-Height Environments with Intelligent Inventory Control

Association for Molecular Pathology Announces 2025 Award Recipients

AMP announced the recipients of its 2025 Excellence in Molecular Diagnostics, Jeffrey A. Kant Leadership and Meritorious Service Awards.

Clearwater Strengthens Cyber Defense in Healthcare and the Defense Industrial Base with Enhanced Threat Intelligence from Google Cloud

Sygnature Discovery Completes Major Enhancement of High-Throughput Chemistry Facilities Following £1 Million Investment

START and Advarra Unite to Deliver Unmatched Speed, Quality, and Predictability for Early-Phase Oncology Trials

START enhances its global leadership by integrating Advarra’s advanced regulatory and technology solutions, creating a seamlessly connected site network to accelerate trials and relieve pressure on the oncology drug development ecosystem.

Amprion Announces Strategic Growth Initiatives, Expanding Access to Breakthrough SAAmplify Test

Appointment; Abzena Appoints Geoffrey M. Glass as Chief Executive Officer

Zymo Research and the Institute for Genome Sciences at the University of Maryland School of Medicine Partner to Host a BioFestival Supporting Scientific Innovation and Academic Research

I hope this email finds you well. My name is Nora Beik, and I am reaching out from Zymo Research to share our latest press release announcing our partnership with the Institute for Genome Sciences (IGS) at the University of Maryland School of Medicine to co-host the BioFestival on October 17, 2025. This event is designed to support emerging scientists, promote interdisciplinary collaboration, and foster disruptive innovation in the life sciences. The BioFestival will feature interactive science booths, professional networking, and the BioDisruptor Grant Competition, where students will compete for over $9,000 in cash prizes and $20,000 in Zymo Research product credits and services. We believe this event will be of significant interest to your readers, especially those focused on life sciences, academic research, biotechnology innovation, and student-driven discovery. You can view the full press release here: https://www.zymoresearch.com/blogs/press-releases/university-of-maryland-biofestival

Linus Health Showcases Digital Breakthroughs to Advance Early Detection and Personalization in Brain Health at AAIC 2025

Linus Health Showcases Digital Breakthroughs to Advance Early Detection and Personalization in Brain Health at AAIC 2025

Zymo Research Sets New Standard in NGS Library Prep with Endura™ Tn5 Transposase

I hope this email finds you well. My name is Nora Beik, and I am reaching out from Zymo Research to share our latest press release announcing the launch of Endura™ Tn5 Transposase, a next-generation solution for NGS library preparation workflows. Endura™ Tn5 is specifically engineered for enhanced stability and consistent performance in NGS-based applications. This innovation addresses long-standing challenges in Tn5 technologies, including enzyme instability and variability in fragmentation results. We believe this launch will be of significant interest to your readers in genomics, molecular biology, sequencing technologies, and life science research. You can view the full press release here: https://www.zymoresearch.com/blogs/press-releases/zymo-research-endura-tn5-transposase We would greatly appreciate it if you would consider sharing this news with your readers. If you require any additional information, high-resolution images, or would like to arrange an interview with one of our experts, please do not hesitate to reach out. I look forward to the opportunity to collaborate with your team. Thank you for your time and consideration.

PhenoTips Appoints Growth Driver Parker Lachance as Vice President of Revenue

PhenoTips, a leading provider of precision medicine software, announces today the appointment of Parker Lachance as VP of Revenue. Parker Lachance brings to PhenoTips an extensive history scaling start-ups through sales, marketing, and customer success strategy, most recently as Vice President of Revenue Operations at Smile Digital Health.

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-Class Scientific Research

Dear GenomeWeb Editorial Team, I hope this email finds you well. My name is Nora Beik, and I am reaching out from Zymo Research to share our latest press release announcing the upcoming BioFestival at Harvard University, taking place on October 18, 2025. We believe this event will resonate strongly with your audience, especially those engaged in life sciences, academic research, and biotech innovation. The press release highlights Zymo Research’s partnership with Harvard to celebrate disruptive research, foster academic-industry collaboration, and promote sustainable scientific innovation. With over $9,000 in cash awards and $20,000 in research funding at stake, this event empowers students to advance their research and connect with leaders in the life science community. We invite you to read the full press release here: https://www.zymoresearch.com/blogs/press-releases/harvard-university-biofestival

Sharp's Emissions Reduction Targets Validated by Science Based Targets initiative

Huateng Pharma Highlights the Expanding Role of N-Benzylhydroxylamine Hydrochloride in Drug Discovery

Huateng Pharma spotlights N-Benzylhydroxylamine Hydrochloride (CAS 29601-98-7), a versatile compound used in drug synthesis and biomedical research. Known for its role in HDAC inhibitor development, the compound also shows potential in metal chelation, antioxidant activity, and enzyme modulation. Huateng Pharma supports ongoing pharmaceutical innovation by providing high-purity intermediates like this for global research and development.